Allegiant Private Advisors, LLC
- SEC CIK
- 0001843631
- Latest filing
- Jul 7, 2021
The latest 13F from Allegiant Private Advisors, LLC covers Q2 2021 (filed Jul 7, 2021): 164 long positions worth $618.1M. The top 10 holdings make up 45.4% of the portfolio, and the largest is iShares S&P 500 Growth ETF at 9.7%. Livermore has 2 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2021
Share counts compared with Q1 2021: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 17
- Est. +$5.42M
- Added
- 62
- Est. +$60.8M
- Reduced
- 52
- Est. −$25.8M
- Sold out
- 4
- Est. −$1.67M
Top 5 holdings
Share of this quarter's portfolio value
- iShares S&P 500 Growth ETF4642873099.7%$60.0M
- Vanguard Ftse Developed Markets ETF9219438587.9%$48.7M
- iShares S&P 500 Value ETF4642874084.6%$28.5M
- iShares Core S&P Mid-Cap ETF4642875074.6%$28.3M
- Global X FDS37954Y6573.9%$24.0M
Share of portfolio
Top 5 holdings and the other 159 positions, by share of portfolio value
- iShares S&P 500 Growth ETF9.7%
- Vanguard Ftse Developed Markets ETF7.9%
- iShares S&P 500 Value ETF4.6%
- iShares Core S&P Mid-Cap ETF4.6%
- Global X FDS3.9%
- Other 159 positions69.3%
Biggest buys
New and added positions, by estimated amount bought
- Global X FDS37954Y657+$10.3MAdded
- Vanguard Intermediate-Term Bond ETF921937819+$6.65MAdded
- Vanguard Mun BD FDS922907746+$3.47MAdded
- Vanguard Ftse Emerging Markets ETF922042858+$3.18MAdded
- Fidelity Covington Trust316092204+$3.03MAdded
Largest weight increases
New and added positions, by percentage points of the portfolio gained
- Global X FDS37954Y657+1.45 pp2.4% → 3.9%
- Vanguard Intermediate-Term Bond ETF921937819+0.76 pp3.1% → 3.9%
- Fidelity Covington Trust316092204+0.48 pp0.2% → 0.6%
- Vanguard Mun BD FDS922907746+0.43 pp1.2% → 1.7%
- Vanguard Ftse Emerging Markets ETF922042858+0.41 pp1.4% → 1.8%
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
- iShares Tr464288687−1.61 pp3.8% → 2.2%
- iShares Core S&P Mid-Cap ETF464287507−0.67 pp5.3% → 4.6%
- CVSCVS Health Corp
- iShares S&P 500 Value ETF464287408−0.52 pp5.1% → 4.6%
- iShares Core S&P Small Cap ETF464287804−0.38 pp2.7% → 2.3%
Metrics
13F metrics for Q2 2021, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $618.1M
- +$70.2M (+12.8%) vs. prior quarter
- Positions
- 164
- +13 vs. prior quarter
- Top 10 concentration
- 45.4%
- Top 10 as share of value
- Turnover
- 4.7%
- Q2 2021, one quarter
- Average holding period
- 2.0 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
2 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $618.1M (Q2 2021)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2021 | Jul 7, 2021 | 164 | $618.1M | iShares S&P 500 Growth ETFVanguard Ftse Developed Markets ETFiShares S&P 500 Value ETF | vs. Q1 2021 | SEC |
| Q1 2021 | Apr 15, 2021 | 151 | $547.9M | iShares S&P 500 Growth ETFVanguard Ftse Developed Markets ETFiShares Core S&P Mid-Cap ETF | – | SEC |